|
|
|
|
|
|
by SolarNet
779 days ago
|
|
|
Eh, calling on a company to do a thing is some mix between public fact finding and threat here. It allows the public to comment and maybe the senator will like the public support they are getting. Alternatively a pharma lobbyist will show up and toss them a few hundred thousand in campaign contribution promises. And they'll weight the relative value of those things. Depending on how that goes they (or another senator seeing this play out) will actually make an issue of it and it will start the more formal processes. |
|
|